Gross Profit (Annual) Chart

View Gross Profit (Annual) for LXRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Gross Profit (Annual) Chart
Start Trial

Historical Gross Profit (Annual) Data

View and export this data back to 1996. Start Trial.
Date Value
December 31, 2025 48.91M
December 31, 2024 29.93M
December 31, 2023 0.565M
December 31, 2022 -0.288M
December 31, 2021 0.00
December 31, 2020 20.33M
December 31, 2019 316.99M
December 31, 2018 58.84M
December 31, 2017 87.89M
December 31, 2016 0.00
December 31, 2015 0.00
December 31, 2014 0.00
December 31, 2013 0.00
December 31, 2012 0.00
December 31, 2011 -3.038M
Date Value
December 31, 2010 -0.486M
December 31, 2009 0.00
December 31, 2008 0.00
December 31, 2007 0.00
December 31, 2006 0.00
December 31, 2005 0.00
December 31, 2004 0.00
December 31, 2003 -39.36M
December 31, 2002 -39.66M
December 31, 2001 24.80M
December 31, 2000 -19.81M
December 31, 1999 -11.81M
December 31, 1998 -6.924M
December 31, 1997 -4.319M
December 31, 1996 -2.103M

Gross Profit Definition

Annual, Interim and Preliminary Items - Commercial, Other Financial Companies

Read full definition.

Gross Profit (Annual) Range, Past 5 Years

View Gross Profit (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit (Annual) Benchmarks

View Gross Profit (Annual) Benchmarks
Start Trial
ANI Pharmaceuticals, Inc. 450.64M
Corcept Therapeutics, Inc. 748.43M
Veru, Inc. -0.1521M
Johnson & Johnson 64.63B
Eli Lilly & Co. 54.13B